Some 13 years and $2 billion later, Denali Therapeutics wins first drug approval

The South San Francisco biotechnology company behind it spent 13 years and $2 billion to develop a transport technology that ...

From failure to hit to a $6.7 billion buyout: Terns Pharma gets big offer from Merck

A Bay Area biotech company saw its obesity drug fail in clinical trials just five months ago. Now it's being acquired for ...
WinBuzzer

Anthropic’s Claude Code Gets Auto Mode, Cowork Gains Desktop Control

Anthropic has launched auto mode for Claude Code and computer use for Cowork, expanding AI agent autonomy as revenue ...
The Bromsgrove Standard

'Use it or lose it' plea for Bromsgrove Post Office

MP Bradley Thomas has urged residents to use the towns Post Office counter in TG Jones on Bromsgrove High Street after it was ...
Labroots

GLP-1 Drugs Show Promise for Substance Use Disorders

Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity could help reduce risk of addiction to substances like cannabis, alcohol, and cocaine. The corresponding ...